WI
CRL icon

WrapManager Inc’s Charles River Laboratories CRL Stock Holding History

WrapManager Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,307
Closed -$270K – 246
2024
Q2 		$270K Sell
1,307
-172
-12% -$39K 0.07% 209
2024
Q1 		$401K Buy
1,479
+199
+16% +$47.5K 0.11% 149
2023
Q4 		$303K Sell
1,280
-295
-19% -$58K 0.09% 203
2023
Q3 		$309K Sell
1,575
-152
-9% -$31.2K 0.1% 193
2023
Q2 		$363K Sell
1,727
-84
-5% -$16.7K 0.11% 176
2023
Q1 		$365K Buy
1,811
+332
+22% +$75.2K 0.11% 194
2022
Q4 		$322K Sell
1,479
-359
-20% -$78.4K 0.1% 198
2022
Q3 		$362K Buy
1,838
+161
+10% +$34.8K 0.12% 168
2022
Q2 		$359K Buy
1,677
+257
+18% +$62.8K 0.11% 186
2022
Q1 		$403K Buy
1,420
+671
+90% +$207K 0.11% 183
2021
Q4 		$282K Buy
+749
New +$291K 0.07% 248

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

WrapManager Inc's CRL Position: Q3 2024 in Review

WrapManager Inc sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 1,307 shares — an estimated $270K sold.

WrapManager Inc first reported a position in CRL in Q4 2021 and held it in 11 quarters. The position peaked at $403K in Q1 2022. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • WrapManager Inc reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • WrapManager Inc sold 1,307 Charles River Laboratories shares in Q3 2024, an estimated $270K.
  • WrapManager Inc first reported a position in Charles River Laboratories in Q4 2021 and held it in 11 quarters.
  • WrapManager Inc's Charles River Laboratories position peaked at $403K in Q1 2022.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on WrapManager Inc's 13F filing for Q3 2024, filed 7 Nov 2024.